Prospective Study of Withdrawal of Antiviral Therapy in Patients with Chronic Hepatitis B after Prolonged Virological Response

Nucleoside analogue (NA) therapy for chronic hepatitis B (CHB) is associated with improved clinical outcomes, but usually requires long‐term use. Whether treatment can be safely withdrawn and the factors associated with post‐withdrawal outcome are not well defined. To assess long‐term outcomes after...

Descripción completa

Detalles Bibliográficos
Autores principales: Gara, Naveen, Tana, Michele M., Kattapuram, Meera, Auh, Sungyoung, Sullivan, Lauren, Fryzek, Nancy, Walter, Mary, Umarova, Regina, Zhao, Xiongce, Cloherty, Gavin, Doo, Edward, Heller, Theo, Liang, T. Jake, Ghany, Marc G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8557321/
https://www.ncbi.nlm.nih.gov/pubmed/34558806
http://dx.doi.org/10.1002/hep4.1761

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8557321/
https://www.ncbi.nlm.nih.gov/pubmed/34558806
http://dx.doi.org/10.1002/hep4.1761

Ejemplares similares